Trial · NCT07895121
3D-Printed Versus Conventional Palatal Cribs in Managing Tongue Thrusting Habit in Children
NCT07895121, Not applicable, Recruiting, Tanta University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. 3D-Printed Versus Conventional Palatal Cribs in Managing Tongue Thrusting Habit in Children. Trials, record NCT07895121. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895121
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- 3D-Printed Versus Conventional Palatal Cribs in Managing Tongue Thrusting Habit in Children
- NCT number
- NCT07895121
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Tanta University
- Conditions
- 3D Printing, Oral Habit, Patient Comfort
- Interventions
- 3D-Printed Palatal Crib Appliance Therapy (Group I):, Conventional Soldered Palatal Crib Appliance Therapy (Group II)
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Dentoalveolar Dimensional Changes (Dental Cast Analysis) | Baseline (T1) and 6 months post-cementation (T2). | Measure: Changes in dental arch dimensions measured from digital models (STL files) generated from initial scans (T1) and 6-month post-treatment scans (T2) using 3D analysis software. Parameters measured include: Overjet , Overbite , Intercanine width, Intermolar width, Arch length |
| Secondary | Appliance Cumulative Survival | At 2 weeks, 1 month, 2 months, 3 months, 4 months, 5 months, and 6 months post-cementation. | Proportion of appliances remaining fully intact and functional without major failure events, expressed as a cumulative percentage. |
| Secondary | Failure Rate | At 2 weeks, 1 month, 2 months, 3 months, 4 months, 5 months, and 6 months post-cementation. | Failure is defined as the occurrence of any of the following binary clinical events (Yes/No): complete debonding, solder joint breakage, band loosening, or crib dislodgement requiring repair or remaking. |
| Secondary | Gingival Index Score | Baseline (pre-cementation), 2 weeks, 1 month, 2 months, 3 months, 4 months, 5 months, and 6 months post-cementation. | Evaluation of marginal gingival tissue health surrounding the anchor molars using the Löe-Silness Gingival Index. Scored on a 0 to 3 scale across four surfaces per tooth (mesial, distal, buccal, lingual): 0 = Normal gingiva, no inflammation; 1. = Mild inflammation, slight erythema, no bleeding; 2. = Moderate inflammation, erythema, bleeding on probing; 3. = Severe inflammation, severe erythema/edema, tendency to spontaneous bleeding. Scores across the four surfaces are averaged. |
| Secondary | Patient Comfort and Acceptance | Assessed during initial adaptation and follow-up intervals over the 6-month study period. | Measure: Evaluation of patient-reported perceptions regarding speech interference, eating difficulty, pain/discomfort, and overall satisfaction using a structured questionnaire. |
| Secondary | Plaque Index Score | Baseline (pre-cementation), 2 weeks, 1 month, 2 months, 3 months, 4 months, 5 months, and 6 months post-cementation. | Evaluation of soft deposit accumulation along the gingival margin of anchor teeth using the Silness-Löe Plaque Index. Scored on a 0 to 3 scale across four surfaces per tooth (mesial, distal, buccal, lingual): 0 = No plaque; 1. = Thin film at free gingival margin visible only on probing; 2. = Moderate accumulation of soft deposits visible to naked eye; 3. = Abundance of soft matter within sulcus/pocket. Scores across the four surfaces are averaged. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895121
GET https://conductscience.org/api/trials/v1/NCT07895121/registered